Table of Contents Author Guidelines Submit a Manuscript
Analytical Cellular Pathology
Volume 2018, Article ID 3506874, 12 pages
https://doi.org/10.1155/2018/3506874
Research Article

Molecular Detection of EMT Markers in Circulating Tumor Cells from Metastatic Non-Small Cell Lung Cancer Patients: Potential Role in Clinical Practice

1Department of Molecular and Clinical Medicine, School of Medicine and Psychology, Sapienza University of Rome, Rome, Italy
2Oncology Unit, Sant’Andrea University Hospital, Rome, Italy
3Cellular Diagnostics Unit, Sant’Andrea University Hospital, Rome, Italy

Correspondence should be addressed to Salvatore Raffa; ti.1amorinu@affar.erotavlas

Received 30 August 2017; Revised 3 November 2017; Accepted 11 December 2017; Published 27 February 2018

Academic Editor: Fernando Schmitt

Copyright © 2018 Annalisa Milano et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. J. Allard, J. Matera, M. C. Miller et al., “Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases,” Clinical Cancer Research, vol. 10, no. 20, pp. 6897–6904, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Lamouille, J. Xu, and R. Derynck, “Molecular mechanisms of epithelial-mesenchymal transition,” Nature Reviews Molecular Cell Biology, vol. 15, no. 3, pp. 178–196, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. J. P. Sleeman and J. P. Thiery, “SnapShot: the epithelial-mesenchymal transition,” Cell, vol. 145, no. 1, pp. 162–162.e1, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. J. I. Bàrdos and M. Ashcroft, “Negative and positive regulation of HIF-1: a complex network,” Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol. 1755, no. 2, pp. 107–120, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Moustakas and C. H. Heldin, “Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression,” Cancer Science, vol. 98, no. 10, pp. 1512–1520, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Sánchez-Tilló, Y. Liu, O. de Barrios et al., “EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness,” Cellular and Molecular Life Sciences, vol. 69, no. 20, pp. 3429–3456, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation,” Cell, vol. 144, no. 5, pp. 646–674, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Yu, S. Stott, M. Toner, S. Maheswaran, and D. A. Haber, “Circulating tumor cells: approaches to isolation and characterization,” The Journal of Cell Biology, vol. 192, no. 3, pp. 373–382, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. N. J. Caixeiro, N. Kienzle, S. H. Lim et al., “Circulating tumour cells—a bona fide cause of metastatic cancer,” Cancer Metastasis Reviews, vol. 33, no. 2-3, pp. 747–756, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. G. T. Budd, M. Cristofanilli, M. J. Ellis et al., “Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer,” Clinical Cancer Research, vol. 12, no. 21, pp. 6403–6409, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. S. J. Cohen, C. J. A. Punt, N. Iannotti et al., “Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer,” Journal of Clinical Oncology, vol. 26, no. 19, pp. 3213–3221, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. J. S. de Bono, H. I. Scher, R. Bruce Montgomery et al., “Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer,” Clinical Cancer Research, vol. 14, no. 19, pp. 6302–6309, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal, “Global cancer statistics, 2012,” CA: a Cancer Journal for Clinicians, vol. 65, no. 2, pp. 87–108, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. M. G. Krebs, R. Sloane, L. Priest et al., “Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer,” Journal of Clinical Oncology, vol. 29, no. 12, pp. 1556–1563, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Hanssen, S. Loges, K. Pantel, and H. Wikman, “Detection of circulating tumor cells in non-small cell lung cancer,” Frontiers in Oncology, vol. 5, p. 207, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Tang, G. Qiao, E. Xu, Y. Xuan, M. Liao, and G. Yin, “Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer,” OncoTargets and Therapy, vol. 10, pp. 4527–4534, 2017. View at Publisher · View at Google Scholar
  17. C. Alix-Panabières and K. Pantel, “Circulating tumor cells: liquid biopsy of cancer,” Clinical Chemistry, vol. 59, no. 1, pp. 110–118, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. P. K. Grover, A. G. Cummins, T. J. Price, I. C. Roberts-Thomson, and J. E. Hardingham, “Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research,” Annals of Oncology, vol. 25, no. 8, pp. 1506–1516, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. E. E. Van der Toom, J. E. Verdone, M. A. Gorin, and K. J. Pienta, “Technical challenges in the isolation and analysis of circulating tumor cells,” Oncotarget, vol. 7, no. 38, pp. 62754–62766, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Bozzetti, F. Quaini, A. Squadrilli et al., “Isolation and characterization of circulating tumor cells in squamous cell carcinoma of the lung using a non-EpCAM-based capture method,” PLoS One, vol. 10, no. 11, article e0142891, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Lecharpentier, P. Vielh, P. Perez-Moreno, D. Planchard, J. C. Soria, and F. Farace, “Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer,” British Journal of Cancer, vol. 105, no. 9, pp. 1338–1341, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Yin, Y. Wang, H. Yin et al., “Circulating tumor cells enriched by the depletion of leukocytes with bi-antibodies in non-small cell lung cancer: potential clinical application,” PLoS One, vol. 10, no. 8, article e0137076, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Yu, J. Zhou, F. Cui, and X. Tang, “Circulating tumor cells in lung cancer: detection methods and clinical applications,” Lung, vol. 193, no. 2, pp. 157–171, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Pailler, J. Adam, A. Barthélémy et al., “Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer,” Journal of Clinical Oncology, vol. 31, no. 18, pp. 2273–2281, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Ilie, E. Long, C. Butori et al., “ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma,” Annals of Oncology, vol. 23, no. 11, pp. 2907–2913, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Pailler, N. Auger, C. R. Lindsay et al., “High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer,” Annals of Oncology, vol. 26, no. 7, pp. 1408–1415, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Maheswaran, L. V. Sequist, S. Nagrath et al., “Detection of mutations in EGFR in circulating lung-cancer cells,” New England Journal of Medicine, vol. 359, no. 4, pp. 366–377, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Leone, F. Mazzetta, D. Martinelli et al., “Klebsiella pneumoniae is able to trigger epithelial-mesenchymal transition process in cultured airway epithelial cells,” PLoS One, vol. 11, no. 1, article e0146365, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Kasai, J. T. Allen, R. M. Mason, T. Kamimura, and Z. Zhang, “TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT),” Respiratory Research, vol. 6, no. 1, p. 56, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Romiti, S. Raffa, R. Di Rocco et al., “Circulating tumor cells count predicts survival in colorectal cancer patients,” Journal of Gastrointestinal and Liver Diseases, vol. 23, no. 3, pp. 279–284, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Rossi Del Monte, D. Ranieri, F. Mazzetta et al., “Free peritoneal tumor cells detection in gastric and colorectal cancer patients,” Journal of Surgical Oncology, vol. 106, no. 1, pp. 17–23, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Xu, G. Shen, M. Cheng, W. Xu, G. Shen, and S. Hu, “Clinicopathological and prognostic significance of circulating tumor cells in patients with lung cancer: a meta-analysis,” Oncotarget, vol. 8, pp. 62524–62536, 2017. View at Publisher · View at Google Scholar
  33. S. Wu, S. Liu, Z. Liu et al., “Classification of circulating tumor cells by epithelial-mesenchymal transition markers,” PLoS One, vol. 10, no. 4, article e0123976, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Hanssen, J. Wagner, T. M. Gorges et al., “Characterization of different CTC subpopulations in non-small cell lung cancer,” Scientific Reports, vol. 6, no. 1, article 28010, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. D. S. Micalizzi, D. A. Haber, and S. Maheswaran, “Cancer metastasis through the prism of epithelial-to-mesenchymal transition in circulating tumor cells,” Molecular Oncology, vol. 11, no. 7, pp. 770–780, 2017. View at Publisher · View at Google Scholar
  36. J. L. Lì and B. H. P. Zhou, “Activation of β-catenin and Akt pathways by twist are critical for the maintenance of EMT associated cancer stem cell-like characters,” BMC Cancer, vol. 11, no. 1, p. 49, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. B. Roth, I. Jayaratna, D. Sundi et al., “Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis,” Oncotarget, vol. 8, no. 21, pp. 34205–34222, 2017. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Wang, J. Shi, K. Chai, X. Ying, and B. P. Zhou, “The role of snail in EMT and tumorigenesis,” Current Cancer Drug Targets, vol. 13, no. 9, pp. 963–972, 2013. View at Publisher · View at Google Scholar
  39. J. A. Galván, M. Helbling, V. H. Koelzer et al., “TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer,” Oncotarget, vol. 6, no. 2, pp. 874–885, 2015. View at Publisher · View at Google Scholar
  40. H. Peinado, D. Olmeda, and A. Cano, “Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?” Nature Reviews Cancer, vol. 7, no. 6, pp. 415–428, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Yanagawa, T. C. Walser, L. X. Zhu et al., “Snail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinoma,” Clinical Cancer Research, vol. 15, no. 22, pp. 6820–6829, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. Q. Q. Li, Z. Q. Chen, X. X. Cao et al., “Involvement of NF-κB/miR-448 regulatory feedback loop in chemotherapy-induced epithelial-mesenchymal transition of breast cancer cells,” Cell Death and Differentiation, vol. 18, no. 1, pp. 16–25, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Xiao and J. He, “Epithelial mesenchymal transition and lung cancer,” Journal of Thoracic Diseases, vol. 2, no. 3, pp. 154–159, 2010. View at Publisher · View at Google Scholar
  44. I. Nel, U. Jehn, T. Gauler, and A. C. Hoffmann, “Individual profiling of circulating tumor cell composition in patients with non-small cell lung cancer receiving platinum based treatment,” Translational Lung Cancer Research, vol. 3, no. 2, pp. 100–106, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Koren, E. Sodja, M. Rijavec et al., “Prognostic value of cytokeratin-7 mRNA expression in peripheral whole blood of advanced lung adenocarcinoma patients,” Cellular Oncology, vol. 38, no. 5, pp. 387–395, 2015. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Singh and J. Settleman, “EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer,” Oncogene, vol. 29, no. 34, pp. 4741–4751, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. K. Polyak and R. A. Weinberg, “Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits,” Nature Reviews Cancer, vol. 9, no. 4, pp. 265–273, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. J. P. Thiery, H. Acloque, R. Y. Huang, and M. A. Nieto, “Epithelial-mesenchymal transitions in development and disease,” Cell, vol. 139, no. 5, pp. 871–890, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. Z. X. Wu, Z. Liu, H. L. Jiang, H. M. Pan, and W. D. Han, “Circulating tumor cells predict survival benefit from chemotherapy in patients with lung cancer,” Oncotarget, vol. 7, no. 41, pp. 67586–67596, 2016. View at Publisher · View at Google Scholar · View at Scopus
  50. Z. Zhang, N. Ramnath, and S. Nagrath, “Current status of CTCs as liquid biopsy in lung cancer and future directions,” Frontiers in Oncology, vol. 5, p. 209, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. E. S. Lianidou, A. Markou, and A. Strati, “Molecular assays for the detection and molecular characterization of CTCs,” in Circulating Tumor Cells. Current Cancer Research, R. Cote and R. Datar, Eds., pp. 47–74, Springer, New York, NY, USA, 2016. View at Publisher · View at Google Scholar